Cytosorbents EBITDA 2010-2025 | CTSO
Cytosorbents ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Cytosorbents Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-15 |
| 2023 | $-30 |
| 2022 | $-30 |
| 2021 | $-22 |
| 2020 | $-9 |
| 2019 | $-18 |
| 2018 | $-15 |
| 2017 | $-10 |
| 2016 | $-11 |
| 2015 | $-9 |
| 2014 | $-7 |
| 2013 | $-4 |
| 2012 | $-3 |
| 2011 | $-3 |
| 2010 | $-3 |
| 2009 | $-3 |
| Cytosorbents Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-3 |
| 2024-12-31 | $-4 |
| 2024-09-30 | $-4 |
| 2024-06-30 | $-3 |
| 2024-03-31 | $-4 |
| 2023-12-31 | $-9 |
| 2023-09-30 | $-7 |
| 2023-06-30 | $-6 |
| 2023-03-31 | $-8 |
| 2022-12-31 | $-6 |
| 2022-09-30 | $-9 |
| 2022-06-30 | $-8 |
| 2022-03-31 | $-8 |
| 2021-12-31 | $-9 |
| 2021-09-30 | $-5 |
| 2021-06-30 | $-5 |
| 2021-03-31 | $-3 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $-2 |
| 2020-06-30 | $-3 |
| 2020-03-31 | $-2 |
| 2019-12-31 | $-5 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $-3 |
| 2019-03-31 | $-4 |
| 2018-12-31 | $-5 |
| 2018-09-30 | $-3 |
| 2018-06-30 | $-4 |
| 2018-03-31 | $-3 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-2 |
| 2017-06-30 | $-2 |
| 2017-03-31 | $-1 |
| 2016-12-31 | $-5 |
| 2016-09-30 | $-2 |
| 2016-06-30 | $-3 |
| 2016-03-31 | $-2 |
| 2015-12-31 | $-3 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-2 |
| 2015-03-31 | $-2 |
| 2014-12-31 | $-3 |
| 2014-09-30 | $-1 |
| 2014-06-30 | $-1 |
| 2014-03-31 | $-1 |
| 2013-12-31 | $-1 |
| 2013-09-30 | $-1 |
| 2013-06-30 | $-1 |
| 2013-03-31 | $-1 |
| 2012-12-31 | $-1 |
| 2012-09-30 | $-1 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-1 |
| 2011-12-31 | $-1 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $-1 |
| 2011-03-31 | $-1 |
| 2010-12-31 | $0 |
| 2010-09-30 | $-1 |
| 2010-06-30 | $-1 |
| 2010-03-31 | $-1 |
| 2009-12-31 | $-1 |
| 2009-09-30 | $-1 |
| 2009-06-30 | $-1 |
| 2009-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.068B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.094B | 27.91 |
| Boston Scientific (BSX) | United States | $148.004B | 37.05 |
| Stryker (SYK) | United States | $145.912B | 30.51 |
| EssilorLuxottica (ESLOY) | France | $130.051B | 0.00 |
| Medtronic (MDT) | Ireland | $112.158B | 15.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.407B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.971B | 27.90 |
| ResMed (RMD) | United States | $36.801B | 27.64 |
| Agilent Technologies (A) | United States | $33.162B | 21.62 |
| GE HealthCare Technologies (GEHC) | United States | $32.817B | 15.58 |
| Terumo (TRUMY) | Japan | $26.665B | 34.63 |
| Koninklijke Philips (PHG) | Netherlands | $22.070B | 15.86 |
| Insulet (PODD) | United States | $21.511B | 84.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.366B | 11.80 |
| Baxter (BAX) | United States | $15.831B | 11.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.086B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.138B | 21.36 |
| Lantheus Holdings (LNTH) | United States | $5.758B | 14.52 |
| Prestige Consumer Healthcare (PBH) | United States | $4.234B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.598B | 9.12 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.442B | 15.68 |
| ICU Medical (ICUI) | United States | $3.353B | 24.73 |
| Envista Holdings (NVST) | United States | $3.224B | 26.79 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.043B | 14.05 |
| LeMaitre Vascular (LMAT) | United States | $1.883B | 42.08 |
| AtriCure (ATRC) | United States | $1.692B | 0.00 |
| Acuren (TIC) | United States | $1.348B | 0.00 |
| Neogen (NEOG) | United States | $1.198B | 15.33 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.132B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.087B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.082B | 24.33 |
| Phibro Animal Health (PAHC) | United States | $0.982B | 12.55 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.644B | 0.00 |
| Evolus (EOLS) | United States | $0.622B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.08 |
| Capricor Therapeutics (CAPR) | United States | $0.611B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.581B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.413B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.351B | 12.91 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.327B | 58.20 |
| Canopy Growth (CGC) | Canada | $0.298B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Cresco Labs (CRLBF) | United States | $0.263B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 11.89 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.258B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.215B | 6.05 |
| OraSure Technologies (OSUR) | United States | $0.214B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.05 |
| Quanterix (QTRX) | United States | $0.196B | 0.00 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.08 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.184B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.40 |
| Vireo Growth (VREOF) | United States | $0.129B | 0.00 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.50 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.43 |
| United-Guardian (UG) | United States | $0.038B | 13.25 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |